Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00298766
Status:
COMPLETED
Last Update Posted:
2012-06-25
First Post:
2006-03-01
Brief Title:
Open-Label Phase 12 Study of VELCADE for Injection in Patients With Light-chain AL-Amyloidosis
Sponsor:
Millennium Pharmaceuticals Inc
Organization:
Millennium Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Amyloidosis |
Keywords: